DE MARCO, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 481
EU - Europa 159
AS - Asia 78
SA - Sud America 4
Totale 722
Nazione #
US - Stati Uniti d'America 478
IT - Italia 65
VN - Vietnam 49
IE - Irlanda 36
GB - Regno Unito 31
CN - Cina 23
UA - Ucraina 10
BE - Belgio 6
DE - Germania 5
CO - Colombia 4
CA - Canada 3
SG - Singapore 3
FI - Finlandia 2
AT - Austria 1
CZ - Repubblica Ceca 1
ES - Italia 1
IN - India 1
IR - Iran 1
SE - Svezia 1
UZ - Uzbekistan 1
Totale 722
Città #
Chandler 122
Dong Ket 49
Dublin 36
Princeton 34
Fairfield 28
Wilmington 26
Redmond 22
Woodbridge 20
Cambridge 15
Bologna 13
Beijing 12
Udine 11
Houston 10
Codroipo 9
Ogden 9
Ashburn 7
Milan 7
Ann Arbor 6
Brussels 6
Buffalo 6
Norwalk 5
Bogotá 4
Reggio Emilia 4
Seattle 4
Nanjing 3
Rome 3
San Diego 3
Singapore 3
Casarsa della Delizia 2
Chengdu 2
Jacksonville 2
New York 2
Ottawa 2
Pittsburgh 2
Scafati 2
Shenzhen 2
Wuhan 2
Boardman 1
Brno 1
Cologna Veneta 1
Des Moines 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Helsinki 1
Hyderabad 1
Lappeenranta 1
Monfalcone 1
Muenster 1
Munich 1
Palmanova 1
Paola 1
Redwood City 1
Tehran 1
Toronto 1
Venice 1
Vienna 1
Viterbo 1
Totale 516
Nome #
Stimuli-responsive local drug molecule delivery to adhered cells in a 3D nanocomposite scaffold 67
In-Peptide Synthesis of Imidazolidin-2-one Scaffolds, Equippable with Proteinogenic or Taggable/Linkable Side Chains, General Promoters of Unusual Secondary Structures 54
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist 48
Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein 42
Cyclopeptide analogs for generating new molecular and 3D diversity 32
Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects 29
. DS-70, a novel and potent 4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs 28
APE1 interacts with the nuclear exosome complex protein MTR4 and is involved in cisplatin- and 5-fluorouracil-induced RNA damage response 27
Antiangiogenic effect of dual/selective α5 β1/αvβ3 integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics 26
Design and characterization of opioid ligands based on cycle-in-macrocycle scaffold 25
Expedient synthesis of pseudo-Pro-containing peptides: Towards constrained peptidomimetics and foldamers 25
Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-d-alanine 25
In-peptide synthesis of di-oxazolidinone and dehydroamino acid-oxazolidinone motifs as β-turn inducers 25
Heterocyclic Scaffolds in the Design of Peptidomimetic Integrin Ligands: Synthetic Strategies, Structural Aspects, and Biological Activity 25
Chemical modifications designed to improve peptide stability: Incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization 24
Diagnostic implementation of fast and selective integrin-mediated adhesion of cancer cells on functionalized zeolite L monolayers 23
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 23
Investigation of the interaction between the atypical agonist c[YpwFG] and MOR 21
High production of secondary metabolites and biological activities of Cydonia oblonga Mill. pulp fruit callus 19
The inverse type II β-Turn on D-Trp-Phe, a Pharmacophoric Motif for MOR Agonists 18
Synthesis and Analysis of the Conformational Preferences of 5-Aminomethyloxazolidine-2,4-dione Scaffolds: First Examples of β2- and β2, 2-Homo-Freidinger Lactam Analogues 18
15N-Urea release evaluation from two types of mesoporous silica nanoparticles: perspectives for future application as slow release nanofertilizer 18
Easy preparation of dehydroalanine building blocks equipped with oxazolidin-2-one chiral auxiliaries, and applications to the stereoselective synthesis of substituted tryptophans 17
Opioid activity profiles of oversimplified peptides lacking in the protonable N-terminus 17
Editorial: Integrin Ligands and Their Bioconjugate Systems: Synthesis, Conformation, and Biological Activity 16
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist 16
5-aminomethyloxazolidine-2,4-dione hybrid α/β-dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists 14
Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells 12
Synthesis and conformational analysis of cyclotetrapeptide mimetic β-turn templates and validation as 3D scaffolds 11
Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic 11
Synthesis and assay of retro-α4β1 integrin-targeting motifs 11
POM@PMO plastic electrode for phosphate electrochemical detection: a further improvement of the detection limit 11
Strategies to Improve Bioavailability and In Vivo Efficacy of the Endogenous Opioid Peptides Endomorphin-1 and Endomorphin-2 10
Versatile Picklocks to Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe- d -Pro-Phe-Trp] (CJ-15,208) 10
Selective detection of α4β1 integrin (VLA-4)-expressing cells using peptide-functionalized nanostructured materials mimicking endothelial surfaces adjacent to inflammatory sites 10
Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model 9
Modern tools for the chemical ligation and synthesis of modified peptides and proteins 9
Synthesis of tripeptides containing d-Trp substituted at the indole ring, assessment of opioid receptor binding and in vivo central antinociception 9
Tryptophan-Containing Non-Cationizable Opioid Peptides - A new chemotype with unusual structure and in vivo activity 9
Peptide direct growth on poly(acrylic acid)/poly(vinyl alcohol) electrospun fibers coated with branched poly(ethylenimine): A solid-phase approach for scaffolds biofunctionalization 2
Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells 1
Totale 847
Categoria #
all - tutte 7.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 0 0 0 0 0 0 16 8 11 12 9 2
2020/2021232 49 20 16 6 2 11 0 8 25 4 28 63
2021/2022153 1 7 0 4 0 0 11 14 8 34 30 44
2022/2023285 40 22 21 8 43 65 0 19 38 11 9 9
2023/2024115 25 7 6 9 9 11 5 3 13 5 13 9
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 847